Author:
Parra H. J.,Cachera C.,Equagoo K.,Dracon M.,Fruchart J. C.,Tacquet A.
Reference16 articles.
1. P. Puchois, P. Alaupovic, and J.C. Fruchart, Mise au point sur les classifications des lipoproteines plasmatiques, Ann. Biol. Clin. 43:831 (1985).
2. P. Alaupovic, C.S. Wang, W.J. McConathy, D. Wei ser, and D. Downs, Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase : the identification of lipoprotein B as the main lipoprotein degradation product, Arch Biochem. Biophys. 244:226 (1986).
3. P.O. Attman, P. Alaupovic, C. Knight, C.S. Wang, and H. Bass, Apolipoprotein pattern in patients with chronic renal failure, Contr. Nephrol. 41:328 (1984).
4. P. O. Attman, P. Alaupovic, and A. Gustafson, Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int. 32:368 ( 1987).
5. D. Parsy, M. Draeon, C. Cachera, H.J. Parra, G. Vanhoutte, A. Tacquet, and J.C. Fruchart, Lipoprotein abnormalities in chronic haemodialysis patients. Nephrology Dialysis and Transplantation (in press), 1988.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preventing Cardiovascular Outcome in Patients with Renal Impairment;American Journal of Cardiovascular Drugs;2005
2. REFERENCES;American Journal of Kidney Diseases;2003-04